7 October 2017 - A supercharged vaccine that protects against several deadly cancers will be provided for free to all ...
9 October 2017 - A breakthrough leukaemia and lymphoma drug that normally costs $187,000 per treatment will become easily affordable ...
5 October 2017 - AbbVie has struck a deal with NICE to make its leukaemia drug Venclyxto available through the ...
6 October 2017 - Public hospitals can access 44% more funding for patients if they bill their insurer, according to ...
5 October 2017 - Figures show spending slowing, but not to the same extent as GDP growth, as health economist says ...
6 October 2017 - PHARMAC is pleased to announce the approval of agreements with Medtronic New Zealand Limited (“Medtronic”) and ...
4 October 2017 - The ABPI have issued a statement regarding its application for judicial review versus NICE. ...
2 October 2017 - Dr. Brian O’Rourke, CADTH President and Chief Executive Officer, is pleased to announce the appointment of four ...
4 October 2017 - Five decades on from an important speech about fixing Australia’s healthcare system, better policy is still ...
4 October 2017 - The agenda for the December 2017 PBAC meeting, to be held on 15 December 2017, is ...
4 October 2017 - PHARMAC is seeking feedback on a proposal to list a range of medical thermometer and venous thromboembolism ...
28 September 2017 - In September 2016, CADTH updated the advance notification procedure for the Common Drug Review. ...
1 October 2017 - Is it fair that melanoma gets funded for a particular drug while lung cancer doesn't? ...
30 September 2017 - This week, the Patented Medicine Prices Review Board ruled the Canadian price of the drug Soliris is ...
29 September 2017 - In the third in her series of five articles, Leela Barham considers the extent to which ...